Assessment of serum angiotensin-converting enzyme in patients with epithelial ovarian cancer

Archives of Gynecology and Obstetrics

Volumn 292, Issue 2, 2015, Pages 415-420

  Beyazit, Fatma ^a   Ayhan, Sevgi ^b   Celik, Huseyin Tugrul ^c   Gungor, Tayfun ^b  

^a Canakkale State Hospital   (Turkey)

^b Dr Zekai Tahir Burak Women Health Education and Research Hospital   (Turkey)

^c TURGUT OZAL UNIVERSITY   (Turkey)

Author keywords

Angiotensin converting enzyme; Ca 125; Epithelial ovarian carcinoma; Renin angiotensin system

Indexed keywords

CA 125 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE; HEMOGLOBIN; ANGIOTENSIN II;

ADULT; ARTICLE; CANCER STAGING; CARCINOGENESIS; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOMETRIUM CARCINOMA; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MUCINOUS ADENOCARCINOMA; OVARIAN SEROUS ADENOCARCINOMA; OVARY ADENOCARCINOMA; OVARY CARCINOMA; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; AGED; BLOOD; CASE CONTROL STUDY; MIDDLE AGED; NEOPLASM; NONPARAMETRIC TEST; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY;

ADULT; AGED; ANGIOTENSIN II; CA-125 ANTIGEN; CASE-CONTROL STUDIES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PEPTIDYL-DIPEPTIDASE A; RENIN-ANGIOTENSIN SYSTEM; STATISTICS, NONPARAMETRIC;

EID: 84930540114     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-015-3661-x     Document Type: Article

References (23)

1. Dietl J (2014) Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tube. Arch Gynecol Obstet 289:241–246
2. Yang Z, Luo Z, Zhao B, Zhang W, Zhang J, Li Z, Li L (2013) Diagnosis and preoperative predictive value of serum HE4 concentrations for optimal debulking in epithelial ovarian cancer. Oncol Lett 6:28–34
3. O’Shannessy DJ, Somers EB, Palmer LM, Thiel RP, Oberoi P, Heath R, Marcucci L (2013) Serum folate receptor alpha, mesothelin and megakaryocyte potentiating factor in ovarian cancer: association to disease stage and grade and comparison to CA125 and HE4. J Ovarian Res 6:29
4. Robati M, Ghaderi A, Mehraban M, Shafizad A, Nasrolahi H, Mohammadianpanah M (2013) Vascular endothelial growth factor (VEGF) improves the sensitivity of CA125 for differentiation of epithelial ovarian cancers from ovarian cysts. Arch Gynecol Obstet 288:859–865
5. Nolen BM, Lokshin AE (2013) Biomarker testing for ovarian cancer: clinical utility of multiplex assays. Mol Diagn Ther 17:139–146
6. Verheijen RH, Cibula D, Zola P, Reed N, Council of the European Society of Gynaecologic Oncology (2012) Cancer antigen 125: lost to follow-up?: a European society of gynaecological oncology consensus statement. Int J Gynecol Cancer 22:170–174
7. Albayrak M, Celebi H, Albayrak A, Sayilir A, Yesil Y, Balcik OS, Yokus O, Celik T (2012) Elevated serum angiotensin converting enzyme levels as a reflection of bone marrow renin-angiotensin system activation in multiple myeloma. J Renin Angiotensin Aldosterone Syst 13:259–264
8. Haznedaroglu IC, Beyazit Y (2010) Pathobiological aspects of the local bone marrow renin-angiotensin system: a review. J Renin Angiotensin Aldosterone Syst 11:205–213
9. Beyazit Y, Ibis M, Purnak T, Turhan T, Kekilli M, Kurt M, Sayilir A, Onal IK, Turhan N, Tas A, Köklü S, Haznedaroglu IC (2011) Elevated levels of circulating angiotensin converting enzyme in patients with hepatoportal sclerosis. Dig Dis Sci 56:2160–2165
10. Ino K, Shibata K, Kajiyama H, Yamamoto E, Nagasaka T, Nawa A, Nomura S, Kikkawa F (2006) Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival. Br J Cancer 94:552–560
11. Beyazit Y, Purnak T, Suvak B, Kurt M, Sayilir A, Turhan T, Tas A, Torun S, Celik T, Ibis M, Haznedaroglu IC (2011) Increased ACE in extrahepatic cholangiocarcinoma as a clue for activated RAS in biliary neoplasms. Clin Res Hepatol Gastroenterol 35:644–649
12. Herr D, Bekes I, Wulff C (2013) Local Renin-Angiotensin system in the reproductive system. Front Endocrinol (Lausanne) 4:150
13. Ager EI, Neo J, Christophi C (2008) The renin-angiotensin system and malignancy. Carcinogenesis 29:1675–1684
14. Haznedaroglu IC, Beyazit Y (2013) Local bone marrow renin-angiotensin system in primitive, definitive and neoplastic haematopoiesis. Clin Sci (Lond) 124:307–323
15. Ni L, Feng Y, Wan H, Ma Q, Fan L, Qian Y, Li Q, Xiang Y, Gao B (2012) Angiotensin-(1-7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the PI3 K/Akt and MAPK signaling pathways. Oncol Rep 27:783–790
16. Fendrich V, Chen NM, Neef M, Waldmann J, Buchholz M, Feldmann G, Slater EP, Maitra A, Bartsch DK (2010) The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer. Gut 59:630–637
17. Cole J, Ertoy D, Lin H, Sutliff RL, Ezan E, Guyene TT, Capecchi M, Corvol P, Bernstein KE (2000) Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice. J Clin Invest 106:1391–1398
18. Erman A, Chen-Gal B, van Dijk DJ, Sulkes J, Kaplan B, Boner G, Neri A (1996) Ovarian angiotensin-converting enzyme activity in humans: relationship to estradiol, age, and uterine pathology. J Clin Endocrinol Metab 81:1104–1107
19. Cotter TP, Kealy NP, Duggan PF, Curtain A, Bredin CP (1997) Elevated serum angiotensin converting enzyme levels in metastatic ovarian dysgerminoma. Respir Med 91:237–239
20. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T (2000) International union of pharmacology. XXIII The angiotensin II receptors. Pharmacol Rev 52:415–472
21. Leung PS, Suen PM, Ip SP, Yip CK, Chen G, Lai PB (2003) Expression and localization of AT1 receptors in hepatic Kupffer cells: its potential role in regulating a fibrogenic response. Regul Pept 116:61–69
22. Suganuma T, Ino K, Shibata K, Kajiyama H, Nagasaka T, Mizutani S, Kikkawa F (2005) Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination. Clin Cancer Res 11:2686–2694
23. Correa-Noronha SA, Noronha SM, Alecrim C, Mesquita Ade C, Brito GS, Junqueira MG, Leite DB, Carvalho CV, Silva ID (2012) Association of angiotensin-converting enzyme I gene I/D polymorphism with endometrial but not with ovarian cancer. Gynecol Endocrinol 28:889–891